These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30677461)

  • 21. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric dermatology inpatient consultations: a retrospective study of 427 cases.
    McMahon P; Goddard D; Frieden IJ
    J Am Acad Dermatol; 2013 Jun; 68(6):926-31. PubMed ID: 23352278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
    Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
    Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate and transient transfusion-associated cutaneous graft-versus-host disease in a child infected by human immunodeficiency virus.
    Klein C; Fraitag S; Foulon E; Raffoux C; Bodemer C; Blanche S
    Am J Med; 1996 Oct; 101(4):445-6. PubMed ID: 8873516
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
    Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
    Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical manifestation and related-risk factors analysis of chronic graft-versus-host disease].
    Weng JY; Du X; Lu ZS
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):168-70. PubMed ID: 23611230
    [No Abstract]   [Full Text] [Related]  

  • 28. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
    Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized graft-versus-host disease of the skin provoked by radiotherapy.
    van de Donk NW; van Dijk MR; Lokhorst HM
    Leuk Res; 2010 Oct; 34(10):e266-7. PubMed ID: 20417557
    [No Abstract]   [Full Text] [Related]  

  • 30. Malar rash in a stem cell transplant recipient.
    Mansh M; Johnson W; Lai J
    JAMA; 2014 Aug; 312(5):547-8. PubMed ID: 25096696
    [No Abstract]   [Full Text] [Related]  

  • 31. Exuberant granulation tissue associated with chronic graft-versus-host disease after transplantation of peripheral blood progenitor cells.
    Barnadas MA; Brunet S; Sureda A; López R; Curell R; Sierra J; Alomar A
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):876-9. PubMed ID: 10534676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
    [No Abstract]   [Full Text] [Related]  

  • 33. Edema with hypoalbuminemia as a rare manifestation of chronic graft versus host disease after allogeneic hematopoietic cell transplant.
    Hogan JJ; Loren AW; Denker MG; Mangan JK
    Leuk Lymphoma; 2017 Aug; 58(8):2008-2010. PubMed ID: 27998198
    [No Abstract]   [Full Text] [Related]  

  • 34. Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients.
    Tumino M; Serafin V; Accordi B; Spadini S; Forest C; Cortese G; Lissandron V; Marzollo A; Basso G; Messina C
    Br J Haematol; 2015 Jan; 168(1):142-5. PubMed ID: 25098229
    [No Abstract]   [Full Text] [Related]  

  • 35. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Turcotte LM; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Ahmed I; Beitinjaneh A; Buchbinder D; Byrne M; Callander N; Chao N; Choi SW; DeFilipp Z; Gadalla SM; Gale RP; Gergis U; Hashmi S; Hematti P; Holmberg L; Inamoto Y; Kamble RT; Lehmann L; MacMillan MA; McIver Z; Nishihori T; Norkin M; O'Brien T; Olsson RF; Reshef R; Saad A; Savani BN; Schouten HC; Seo S; Solh M; Verdonck L; Vij R; Wirk B; Yared J; Horowitz MM; Knight JM; Verneris MR
    Bone Marrow Transplant; 2018 Jul; 53(7):932-937. PubMed ID: 29382954
    [No Abstract]   [Full Text] [Related]  

  • 36. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
    Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
    Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
    Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C
    Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052
    [No Abstract]   [Full Text] [Related]  

  • 38. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response.
    Calkoen FG; Jol-van der Zijde CM; Mearin ML; Schweizer JJ; Jansen-Hoogendijk AM; Roelofs H; van Halteren AG; Egeler RM; van Tol MJ; Ball LM
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1590-9. PubMed ID: 23994245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Dermatology Consultation With Accuracy of Cutaneous Disorder Diagnoses in Hospitalized Patients: A Multicenter Analysis.
    Kroshinsky D; Cotliar J; Hughey LC; Shinkai K; Fox LP
    JAMA Dermatol; 2016 Apr; 152(4):477-80. PubMed ID: 26762199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.